LONDON, March 5, 2026, 08:21 GMT
- Hindustan Unilever has offloaded its full 19.8% stake in Nutritionalab, fetching roughly 3.07 billion rupees for the sale.
- The sale comes after a plan announced in February to shed the stake, part of a “fewer, bigger bets” strategy.
- Unilever is betting on high-end beauty and wellbeing in India, stepping up as rivals crowd the market.
Hindustan Unilever, the Indian arm of Unilever PLC, has wrapped up the sale of its entire stake in Nutritionalab Private Limited, pocketing roughly 3.07 billion Indian rupees, a stock exchange filing dated March 4 shows. The company offloaded its whole 19.8% interest, with the disclosure made under India’s “Regulation 30” rules — a requirement for listed companies to report any material developments. Unilever
This isn’t a transformative move for the group by itself. What’s at stake: Unilever remains under pressure to show that zeroing in on higher-margin segments can deliver, even as demand wobbles—particularly in major emerging economies.
In India, the battle is getting complicated. Online sales are climbing. Fresh brands ramp up fast, pushing big consumer groups to accelerate their portfolio decisions. Acquisitions tell one story, but exits reveal just as much.
Back in February, Hindustan Unilever’s board signed off on selling its Nutritionalab stake to USV Private Limited, calling it a move to sharpen focus on “fewer, bigger bets.” CEO Priya Nair described health and wellbeing as “an important growth vector” for the business and linked the shift to efforts at scaling brands through Unilever’s reach and R&D. Unilever
Hindustan Unilever is putting money behind new capacity in its higher-end segments, aiming to capture more demand in premium categories. According to Akshay D’Souza, a consumer goods consultant, digital and D2C brands—those that primarily reach customers directly online—are making their presence felt. “If you look at personal care, for example, you’ve seen a large flurry of D2C brands,” D’Souza noted. Meanwhile, Unilever CEO Fernando Fernandez has made it clear: the group is pushing harder into beauty and personal care, focusing on premium products and e-commerce, especially in markets like India. Reuters
Pricing pressure has played a role here. Hindustan Unilever moved to lower prices in select segments, Reuters reported, as it looks to hold ground against rivals like Procter & Gamble—the maker of Ariel detergent—and Godrej Consumer Products in India. On the numbers side, Ajay Thakur of Anand Rathi Institutional Equities highlighted recent volume gains as “a bright spot,” though he noted margins have come under strain. Reuters
The parent company is looking at a wider landscape than just India. Unilever has cautioned that its underlying sales growth for 2026 will probably come in at the lower end of its guidance, blaming softer momentum in the US and Europe. Alongside that, the group announced a 1.5 billion euro share buyback. “There are signs of progress at Unilever… however we think it will take time,” RBC Capital Markets analyst James Edwardes Jones wrote after the update. Reuters
The Nutritionalab sale reads more like housekeeping than any real shift in direction. But it’s consistent: shed what won’t scale, double down where there’s potential, push ahead.
But here’s the danger: the market might not stick around. Should consumers opt for cheaper alternatives, or online rivals continue grabbing share, or if premium offerings don’t ramp up quickly, Unilever’s “fewer, bigger” approach could quickly look more like “fewer, slower.”
The filing kept financial details to just the sale price. Now, investors are watching to see how soon both the Indian business and its parent can translate those revamped bets into more reliable volumes and margins.
